Intravitreal Injections by Nurses and Physicians Compared
NCT02359149 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328
Last updated 2019-07-08
Summary
Anti-VEGF agents are given for a variety of previously untreatable eye diseases. The last years indications for their use and consequently the number of patients needing treatment, have been increasing. Most patients require multiple injections. This has resulted in many eye departments administering thousands of injections per year, also at St Olavs University Hospital Trondheim. To cope with this increase in workload, it would be helpful if injections would be given not only by the physicians but also by the nurses. This study's objective is to compare efficiency, patient satisfaction and cost per patient of injections given by nurses and physicians.
Conditions
- Eye Diseases
Interventions
- PROCEDURE
-
intravitreal injections given by a nurse
- PROCEDURE
-
intravitreal injections given by a physician
- PROCEDURE
-
Intravitreal injections
- DRUG
-
Anti-VEGF agents
Sponsors & Collaborators
-
Norwegian University of Science and Technology
collaborator OTHER -
St. Olavs Hospital
lead OTHER
Principal Investigators
-
Marit Fagerli, md · St. Olavs University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- Norway
Study Locations
More Related Trials
-
Intravitreal Injection Site and Perceived Pain
NCT05640895 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 ·Status: COMPLETED ·Phase: PHASE4
-
Single or Combined Protocols for NV-AMD
NCT03552770 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
NCT00709657 ·Status: TERMINATED ·Phase: NA
-
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365 ·Status: COMPLETED
-
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
NCT01854593 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
NCT00684853 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
NCT00370786 ·Status: COMPLETED ·Phase: PHASE3
-
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
NCT04234932 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
NCT00727753 ·Status: COMPLETED
-
Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
NCT03353324 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Neovascular Glaucoma
NCT00384631 ·Status: COMPLETED ·Phase: NA
-
Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
NCT01027468 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab for Central Retinal Vein Occlusion Study
NCT00906685 ·Status: COMPLETED ·Phase: PHASE3
-
Avastin for PDR (Proliferative Diabetic Retinopathy)
NCT01270542 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Combined Triple Procedure in Retinal Vein Occlusion (RVO)
NCT00805064 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Discomfort Assessment After Intravitreal Injections
NCT02806830 ·Status: COMPLETED ·Phase: NA
-
Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
NCT01439178 ·Status: UNKNOWN ·Phase: NA
-
VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
NCT02175940 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222 ·Status: COMPLETED ·Phase: PHASE3